Status:

COMPLETED

Chronic Plaque Psoriasis (Ps) Registry

Lead Sponsor:

AbbVie

Conditions:

Chronic Plaque Psoriasis

Eligibility:

All Genders

18-99 years

Brief Summary

The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).

Detailed Description

ESPRIT is a 10 year registry of patients taking HUMIRA® for Psoriasis. Patients who volunteer to participate will be asked to provide information about their medical history and experiences with HUMIR...

Eligibility Criteria

Inclusion

  • An adult patient (18 years of age or older) with chronic plaque psoriasis who has been prescribed HUMIRA® therapy according to the local product labeling and meets one of the following criteria:
  • New initiated (within 4 weeks of registry entry) on HUMIRA® therapy;
  • Initiated HUMIRA® therapy in the past and:
  • Has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy and the physician can provide source documentation of SAEs, AEs, of Special Interest, and dosing information since initiation of therapy.
  • OR
  • Is entering after participation in an AbbVie HUMIRA (adalimumab) sponsored study and has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy after the completion of AbbVie sponsored study and physician can provide source documentation of SAEs, AEs of Special Interest, and dosing information since initiation of commercial HUMIRA® (defined as a prescribed/non study drug).
  • Patient is willing to consent to data being collected and provided to AbbVie;
  • Patient is capable of and willing to give written informed consent and to comply with the requirements of the registry.

Exclusion

  • \- Patient should not be enrolled if he/she cannot be treated in accordance with the local product label.

Key Trial Info

Start Date :

September 26 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 13 2023

Estimated Enrollment :

6065 Patients enrolled

Trial Details

Trial ID

NCT00799877

Start Date

September 26 2008

End Date

February 13 2023

Last Update

March 15 2024

Active Locations (339)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 85 (339 locations)

1

Southview Medical Group, PC /ID# 20961

Birmingham, Alabama, United States, 35205

2

Total Skin and Beauty Derm Ctr /ID# 17156

Birmingham, Alabama, United States, 35205

3

Inverness Dermatology /ID# 76194

Birmingham, Alabama, United States, 35242

4

McLain Medical Associates, PC /ID# 18351

Birmingham, Alabama, United States, 35242